COYA (STOCKS)
Coya Therapeutics, Inc. Common Stock
$4.670000
-0.020000 (-0.43%)
Prev close: $4.690000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Arun Swaminathan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $116.23M
- Employees
- 8
- P/E (TTM)
- -4.69
- P/B (TTM)
- 2.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.32 | $-0.42 | +0.1016 | +24.10% |
|
Dec 2025 (Q4)
|
$-0.34 | $-0.28 | -0.0617 | -22.17% |
|
Sep 2025 (Q3)
|
$-0.13 | $-0.28 | +0.1488 | +53.37% |
|
Jun 2025 (Q2)
|
$-0.36 | $-0.40 | +0.0407 | +10.16% |
Financial Statements
| Assets | $47.31M |
| Current Assets | $47.06M |
| Noncurrent Assets | $250.34K |
| Fixed Assets | $5.61K |
| Other Non-current Assets | $244.73K |
| Liabilities | $4.03M |
| Current Liabilities | $3.51M |
| Accounts Payable | $1.09M |
| Other Current Liabilities | $2.43M |
| Noncurrent Liabilities | $519.64K |
| Equity | $43.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $43.28M |
| Liabilities And Equity | $47.31M |